Schedule 13G ownership disclosure

Onconova Therapeutics, Inc.

Security class unavailable · CUSIP: 68232V108

Event date: 2016-06-03

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950103-16-013982
Form type
SC 13G/A
Filer
Baxalta Inc
CIK
CIK 1620546
Filed
Jun 07, 2016
Reporting period
Jun 03, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub